Sapien Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.70 Cr
as on 02-07-2024
- Paid Up Capital ₹ 2.61 Cr
as on 02-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 147.49%
(FY 2023)
- Profit 1483.78%
(FY 2023)
- Ebitda 1877.31%
(FY 2023)
- Net Worth 110.90%
(FY 2023)
- Total Assets 203.94%
(FY 2023)
About Sapien Biosciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.70 Cr and a paid-up capital of Rs 2.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ishita Shively, Haripprasad Kovalamuri, Jugnu Jain, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73100TG2012PTC080254
- Company No.
080254
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sapien Biosciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jugnu Jain  | Director | 17-Nov-2012 | Current |
Ishita Shively  | Director | 09-May-2018 | Current |
| Haripprasad Kovalamuri | Director | 08-Nov-2012 | Current |
| Sreevatsa Gopinath | Director | 17-Nov-2012 | Current |
| Nirmal Ganguly | Director | 29-Apr-2017 | Current |
Financial Performance and Corporate Structure Insights of Sapien Biosciences.
Sapien Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 147.49% increase. The company also saw a substantial improvement in profitability, with a 1483.78% increase in profit. The company's net worth Soared by an impressive increase of 110.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sapien Biosciences?
In 2023, Sapien Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saarum Sciences Private LimitedActive 13 years 10 monthsJugnu Jain and Sreevatsa Gopinath are mutual person
Foundation For Disease Elimination And Control Of IndiaActive 8 years 2 monthsNirmal Ganguly is a mutual person
Pushpawati Singhania Hospital & Research InstituteActive 29 years 5 monthsNirmal Ganguly is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sapien Biosciences?
Sapien Biosciences has a workforce of 34 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sapien Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapien Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
